Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.